
Sign up to save your podcasts
Or


Howie and Harlan are joined by cardiologist Ali Rahimi, the founder of ALYKA Health, which uses a personalized mobile app to help patients manage their heart health between doctor's visits. Harlan discusses new developments in GLP-1 obesity drugs, including untested microdose treatments; Howie reviews a landmark study investigating whether broad prostate cancer screening saves lives.
Show notes:
GLP-1 Drugs
"Microdosing aims to extend the lifespan of the GLP-1 compounding market"
NIH: Regulatory Framework for Compounded Preparations
Health & Veritas Episode 140: Lee Schwamm: Smarter Healthcare Systems With AI
"FDA takes on GLP-1 compounding boom with warnings about misleading marketing"
"Should You Microdose GLP-1 Drugs?"
"How microdosing GLP-1 drugs became a longevity 'craze'"
"Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates"
"Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149""Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment"
"How Ozempic's Maker Lost Its Shine After Creating a Wonder Drug"
Ali Rahimi
ALYKA Health
Harlan Krumholz and Ali Rahimi, "Financial Barriers to Health Care and Outcomes After Acute Myocardial Infarction"
"Why High Blood Pressure Matters to Your Health"
Building a Better Delivery System: A New Engineering/Health Care Partnership
NIH: The 21st Century Cures Act
New Evidence on Prostate Cancer Screening and Breast Cancer Treatment
National Cancer Institute: Cancer Stat Facts: Prostate Cancer"
U.S. Preventive Services Task Force: Prostate Cancer: Screening"
"The pros and cons of PSA tests for prostate cancer for midlife and older men"
"Share on European Study of Prostate Cancer Screening — 23-Year Follow-up"
"Early Detection of Prostate Cancer — Time to Fish or Cut Bait"
"Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer"
"Omission of Chest-Wall Irradiation after Mastectomy for Breast Cancer"
In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time.
Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings.
Email Howie and Harlan comments or questions.
By Yale School of Management4.9
5656 ratings
Howie and Harlan are joined by cardiologist Ali Rahimi, the founder of ALYKA Health, which uses a personalized mobile app to help patients manage their heart health between doctor's visits. Harlan discusses new developments in GLP-1 obesity drugs, including untested microdose treatments; Howie reviews a landmark study investigating whether broad prostate cancer screening saves lives.
Show notes:
GLP-1 Drugs
"Microdosing aims to extend the lifespan of the GLP-1 compounding market"
NIH: Regulatory Framework for Compounded Preparations
Health & Veritas Episode 140: Lee Schwamm: Smarter Healthcare Systems With AI
"FDA takes on GLP-1 compounding boom with warnings about misleading marketing"
"Should You Microdose GLP-1 Drugs?"
"How microdosing GLP-1 drugs became a longevity 'craze'"
"Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates"
"Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149""Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment"
"How Ozempic's Maker Lost Its Shine After Creating a Wonder Drug"
Ali Rahimi
ALYKA Health
Harlan Krumholz and Ali Rahimi, "Financial Barriers to Health Care and Outcomes After Acute Myocardial Infarction"
"Why High Blood Pressure Matters to Your Health"
Building a Better Delivery System: A New Engineering/Health Care Partnership
NIH: The 21st Century Cures Act
New Evidence on Prostate Cancer Screening and Breast Cancer Treatment
National Cancer Institute: Cancer Stat Facts: Prostate Cancer"
U.S. Preventive Services Task Force: Prostate Cancer: Screening"
"The pros and cons of PSA tests for prostate cancer for midlife and older men"
"Share on European Study of Prostate Cancer Screening — 23-Year Follow-up"
"Early Detection of Prostate Cancer — Time to Fish or Cut Bait"
"Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer"
"Omission of Chest-Wall Irradiation after Mastectomy for Breast Cancer"
In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time.
Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings.
Email Howie and Harlan comments or questions.

32,091 Listeners

38,484 Listeners

6,779 Listeners

38,781 Listeners

8,770 Listeners

1,569 Listeners

6,381 Listeners

500 Listeners

4,491 Listeners

393 Listeners

16,088 Listeners

2,278 Listeners

1,595 Listeners

1,153 Listeners

99 Listeners